论文部分内容阅读
目的:探讨晚期胃癌中西医结合临床路径的意义及可行性。方法:选择2008年1月—2010年12月在南京中医药大学附属医院肿瘤科治疗的晚期胃癌患者50例为对照组(非路径组);2011年1月—2013年4月在南京中医药大学附属医院肿瘤科入组中西医结合治疗的晚期胃癌患者50例为试验组(临床路径组)。试验组按制定好的临床路径模式进行诊疗与护理及相关康复工作,并统计分析两组患者平均住院时间、健康知识掌握情况、平均住院费用、患者住院满意度。结果:两组患者相比,试验组临床平均住院时间、健康知识掌握情况、平均住院费用、患者住院满意度等方面均优于对照组,差异有统计学意义(P<0.05)。结论:晚期胃癌中西医临床路径的实施可以明显缩短平均住院时间,降低医疗成本,提高患者满意度。
Objective: To explore the significance and feasibility of clinical pathology of integrated traditional Chinese and western medicine in advanced gastric cancer. Methods: From January 2008 to December 2010, 50 patients with advanced gastric cancer who were treated in Department of Oncology, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine were selected as the control group (non-path group). From January 2011 to April 2013, Fifty patients with advanced gastric cancer treated by Integrative Medicine in the Department of Oncology, Affiliated Hospital of University Hospital were selected as experimental group (clinical pathway group). The experimental group according to a good clinical path model diagnosis and treatment and nursing and related rehabilitation work, and statistical analysis of the two groups of patients in the average length of stay, knowledge of health knowledge, the average cost of hospitalization, patient satisfaction. Results: Compared with the control group, the clinical average length of stay, knowledge of health knowledge, average hospitalization expenses, and hospitalization satisfaction of the two groups were statistically significant (P <0.05). Conclusion: The implementation of TCM clinical pathways in advanced gastric cancer can shorten the average hospitalization time, reduce medical costs and improve patient satisfaction.